ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

TVGN vs BDTX // RSI-14 & 200D SMA MOMENTUM

Tevogen Inc. (NASDAQ) VS. Black Diamond Therapeutics Inc. (NASDAQ) • 15-METRIC TALLY: TVGN 0 — BDTX 4
▲ RSI-14 & 200D SMA MOMENTUM LEADER: BDTX
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (TVGN VS. BDTX) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC TVGN BDTX SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% 10.80% -45.80 BDTX /roic <GO>
EV/EBITDA & P/E Valuation — 6.9x — TIE /valuation <GO>
Free Cash Flow Yield -13.02% — — TIE /fcf-yield <GO>
Operating Margin — — — TIE /operating-margins <GO>
Net Profit Margin — — — TIE /net-margins <GO>
Revenue Growth (YoY) — — — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 1/9 5/9 -4.00 BDTX /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum ACTIVE 37.1 45.4 -8.24 BDTX /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $95.2M $106.9M -$11.7M BDTX /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR TVGN REV BDTX REV TVGN GROSS % BDTX GROSS % TVGN FCF BDTX FCF
FY 2025 $0 $0 — — -$12.4M $29.6M
FY 2024 $0 $0 — — -$12.0M -$62.3M
FY 2023 $0 $0 — — -$8.2M -$66.7M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
TVGN // BETA —
BDTX // BETA —